All Things Considered
<iframe src="http://www.npr.org/player/embed/1140476/140476" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
NPR's Snigdha Prakash reports that while small biotech companies are increasingly on the cutting edge of drug development, they often can't handle the accompanying financial pressures.
NPR thanks our sponsors
Become an NPR sponsor